{"id":"W3088332612","doi":"10.1016/j.msard.2020.102492","title":"Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Merck KGaA; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Novartis; Teva Pharmaceutical Industries; Bayer; Celgene; Biogen; Sanofi Genzyme; F. Hoffmann-La Roche; Agence Nationale de la Recherche; Roche; PTC Therapeutics; UCB","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Randomized controlled trial; Anesthesia; Clinical endpoint; Volunteer; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001117946,0.0006179063,0.00163585,0.0002268531,0.0004727968,0.0000871711,0.0003382125,0.0003628255,0.00008259455],"category_scores_gemma":[0.003035921,0.0003848505,0.0003422009,0.001094929,0.0008718551,0.0002706978,0.0004375268,0.0009842779,0.00003243704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001235294,"about_ca_system_score_gemma":0.0001077166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00310218,"about_ca_topic_score_gemma":0.0006636749,"domain_scores_codex":[0.9948109,0.0004739905,0.001649787,0.001130707,0.001162497,0.0007721],"domain_scores_gemma":[0.9952753,0.002742841,0.0005850561,0.000678312,0.0003473676,0.0003711846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.512472,0.0008962873,0.4513496,0.00008793464,0.001053238,0.000003043124,0.01632292,0.001484081,0.004864148,0.000003221292,0.0008381953,0.01062537],"study_design_scores_gemma":[0.4870698,0.0004448784,0.4881545,0.001278561,0.0002493127,3.160168e-7,0.001315242,0.02063186,0.0004377483,0.00000615954,0.00005428934,0.0003574169],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897172,0.001494845,0.00005013241,0.003000593,0.000111928,0.004709057,0.0001532537,0.0001183396,0.0006446541],"genre_scores_gemma":[0.995083,0.003395318,0.0004934805,0.0002446228,0.00005152031,0.0001586219,0.0004165416,0.0001015485,0.00005534305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03680487,"threshold_uncertainty_score":0.9998603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0457979791972268,"score_gpt":0.2463722815112125,"score_spread":0.2005743023139857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}